Cerys Lovatt

816 total citations
6 papers, 298 citations indexed

About

Cerys Lovatt is a scholar working on Molecular Biology, Pharmacology and Computational Theory and Mathematics. According to data from OpenAlex, Cerys Lovatt has authored 6 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Pharmacology and 1 paper in Computational Theory and Mathematics. Recurrent topics in Cerys Lovatt's work include Drug-Induced Hepatotoxicity and Protection (3 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Glutathione Transferases and Polymorphisms (3 papers). Cerys Lovatt is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (3 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Glutathione Transferases and Polymorphisms (3 papers). Cerys Lovatt collaborates with scholars based in United Kingdom, United States and Germany. Cerys Lovatt's co-authors include Neil R. Kitteringham, C. Roland Wolf, Robert Elsby, Christopher E. Goldring, Colin J. Henderson, M. Chamberlain, B. Kevin Park, Maxine Taylor, Harma Ellens and Melinda J. Reese and has published in prestigious journals such as Journal of Biological Chemistry, American Journal of Physiology-Cell Physiology and Chemical Research in Toxicology.

In The Last Decade

Cerys Lovatt

6 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cerys Lovatt United Kingdom 6 148 116 51 44 24 6 298
Kaori Nakamoto United States 5 122 0.8× 160 1.4× 97 1.9× 55 1.3× 17 0.7× 5 359
Elisa Turlizzi Italy 10 106 0.7× 103 0.9× 68 1.3× 24 0.5× 35 1.5× 11 283
Aaron Fullerton United States 11 72 0.5× 123 1.1× 57 1.1× 42 1.0× 22 0.9× 21 272
J. Fred Pritchard United States 6 111 0.8× 45 0.4× 46 0.9× 27 0.6× 39 1.6× 7 285
Pamela K. Ross United States 8 199 1.3× 139 1.2× 59 1.2× 56 1.3× 39 1.6× 9 421
Frederic Moulin United States 8 94 0.6× 133 1.1× 37 0.7× 61 1.4× 49 2.0× 13 362
Larry C. Cheng United States 8 135 0.9× 93 0.8× 131 2.6× 30 0.7× 14 0.6× 12 345
Timothy Moeller United States 9 134 0.9× 161 1.4× 69 1.4× 12 0.3× 28 1.2× 10 356
Chia Hsin Ju United States 5 100 0.7× 112 1.0× 29 0.6× 25 0.6× 31 1.3× 8 332
Bernd Diener Germany 7 84 0.6× 160 1.4× 68 1.3× 187 4.3× 11 0.5× 13 394

Countries citing papers authored by Cerys Lovatt

Since Specialization
Citations

This map shows the geographic impact of Cerys Lovatt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cerys Lovatt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cerys Lovatt more than expected).

Fields of papers citing papers by Cerys Lovatt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cerys Lovatt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cerys Lovatt. The network helps show where Cerys Lovatt may publish in the future.

Co-authorship network of co-authors of Cerys Lovatt

This figure shows the co-authorship network connecting the top 25 collaborators of Cerys Lovatt. A scholar is included among the top collaborators of Cerys Lovatt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cerys Lovatt. Cerys Lovatt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Richert, Lysiane, Audrey Baze, C. Parmentier, et al.. (2016). Cytotoxicity evaluation using cryopreserved primary human hepatocytes in various culture formats. Toxicology Letters. 258. 207–215. 18 indexed citations
2.
Reese, Melinda J., Andrew W. Harrell, Maxine Taylor, et al.. (2012). Preclinical Strategy to Reduce Clinical Hepatotoxicity Using in Vitro Bioactivation Data for >200 Compounds. Chemical Research in Toxicology. 25(10). 2067–2082. 84 indexed citations
3.
Stokes, Alan H., et al.. (2011). Determination of drug concentrations using dried blood spots: investigation of blood sampling and collection techniques in Crl:CD(SD) rats. Laboratory Animals. 45(2). 109–113. 6 indexed citations
4.
Goldring, Christopher E., Neil R. Kitteringham, Rosalind E. Jenkins, et al.. (2005). Development of a transactivator in hepatoma cells that allows expression of phase I, phase II, and chemical defense genes. American Journal of Physiology-Cell Physiology. 290(1). C104–C115. 31 indexed citations
5.
Kitteringham, Neil R., Helen Powell, Rosalind E. Jenkins, et al.. (2003). Protein expression profiling of glutathione S‐transferase pi null mice as a strategy to identify potential markers of resistance to paracetamol‐induced toxicity in the liver. PROTEOMICS. 3(2). 191–207. 31 indexed citations
6.
Elsby, Robert, Neil R. Kitteringham, Christopher E. Goldring, et al.. (2003). Increased Constitutive c-Jun N-terminal Kinase Signaling in Mice Lacking Glutathione S-Transferase Pi. Journal of Biological Chemistry. 278(25). 22243–22249. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026